NCT07538115

Brief Summary

The aim of this study is to evaluate whether there is a difference in hemodynamic events requiring intervention between patients monitored with advanced hemodynamic monitoring using the MostCare system and those monitored with standard monitoring alone during propofol sedation for ERCP procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Mar 2026May 2026

Study Start

First participant enrolled

March 27, 2026

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2026

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Expected
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

29 days

First QC Date

April 13, 2026

Last Update Submit

April 22, 2026

Conditions

Keywords

Advenced hemodynamic MonitorizationERCPSedationPropofolNon-operating room anesthesia

Outcome Measures

Primary Outcomes (1)

  • Number of hemodynamic events requiring clinical intervention during ERCP under propofol sedation

    Hemodynamic events requiring intervention, including hypotension (MAP \<65 mmHg), bradycardia (HR \<50 bpm), hypoxemia (SpO₂ \<92%), or sedation-depth abnormalities requiring treatment adjustment, will be recorded and compared between groups

    From the start of sedation until the end of the ERCP procedure

Study Arms (2)

Group 1 - Standard Monitoring Group

In this group, sedation depth will be monitored using non-invasive arterial blood pressure (NIBP), electrocardiography (ECG), pulse oximetry (SpO₂), and BIS. Arterial cannulation and advanced hemodynamic monitoring will not be applied.

Procedure: Standard Monitoring

Group 2 - Advanced Hemodynamic Monitoring Group

In addition to standard monitoring parameters, radial arterial cannulation will be performed, and advanced hemodynamic variables including cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume index (SVI), systemic vascular resistance and systemic vascular resistance index (SVR), arterial elastance (Ea), cardiac cycle efficiency (CCE), and cardiac power output (CPO) will be monitored using the MostCare system (Vygon, Italy).

Device: Hemodynamic Monitoring

Interventions

Advanced hemodynamic monitoring performed using the MostCare system via radial arterial cannulation during ERCP under propofol sedation.

Group 2 - Advanced Hemodynamic Monitoring Group

Standard intra-procedural monitoring including non-invasive blood pressure, ECG, pulse oximetry, and BIS during ERCP under propofol sedation

Group 1 - Standard Monitoring Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients with ASA physical status III or higher who are scheduled for elective ERCP and managed under propofol sedation while maintaining spontaneous respiration in a single-center tertiary care university hospital setting.

You may qualify if:

  • Adults aged 18 years and older
  • Patients with an ASA physical status score of III or higher scheduled for ERCP
  • Patients maintaining spontaneous respiration
  • Patients who have provided written informed consent

You may not qualify if:

  • Patients requiring general anesthesia
  • Patients requiring mechanical ventilation
  • Patients unsuitable for arterial catheterization due to coagulopathy or local infection
  • Pregnant women
  • Patients who do not sign the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit university

Çorum, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Hemodynamic Monitoring

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisMonitoring, Physiologic

Study Officials

  • Ozgur Yagan, Professor

    Hitit University

    STUDY CHAIR

Central Study Contacts

Sibel Onen Ozdemir, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start

March 27, 2026

Primary Completion

April 25, 2026

Study Completion (Estimated)

May 15, 2026

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations